The next milestone in clinical trial of a measurement system developed to diagnose NAFLD

Abstract

Our publication presents the next important milestone in development of method aimed at the nondestructive diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD). In clinical trials, a specific group of patients (with liver and other carcinomas) were studied. In their case, liver histological examinations are always carried out, which has given us the opportunity to compare bioimpedance spectrum (BIS) data with biopsy results. In our publication, we present the relevant measurement methodology after that we highlight some typical examples that describe the most common pathologies and their associated BIS origins.